Precision medicine in variceal bleeding: Are we there yet?

Area of Science:

• Hepatology
• Gastroenterology
• Clinical Medicine

Background:

• Variceal bleeding is a serious complication of portal hypertension in cirrhosis patients, significantly impacting prognosis.
• Effective management involves preventing initial bleeding and rebleeding, crucial for altering patient outcomes.
• Clinically significant portal hypertension is a primary risk factor for varices and liver decompensation, necessitating vigilant monitoring.

Purpose of the Study:

• To review evidence supporting individualized risk assessment for clinical decision-making in portal hypertension management.
• To evaluate the impact of tailored therapy on clinical outcomes and survival in cirrhosis patients.
• To explore how liver hemodynamics and function assessment guide individualized treatment strategies.

Main Methods:

• Review of existing clinical data and evidence on risk stratification in portal hypertension.
• Analysis of studies evaluating the impact of individualized therapy on prognosis.
• Assessment of tools for monitoring liver hemodynamics and function for risk stratification.

Main Results:

• Individualized treatment based on risk characteristics improves prognosis and survival.
• Primary prophylaxis in high-risk patients enhances decompensation-free survival.
• Risk stratification for acute and recurrent variceal bleeding allows for tailored, survival-improving interventions.

Conclusions:

• Tailoring treatment for portal hypertension based on individual risk factors is key to improving survival in cirrhosis.
• Early identification and intervention in high-risk patients significantly reduce mortality and morbidity.
• Integrating liver function and hemodynamic assessments enables personalized management strategies for better patient outcomes.